FDA Moves To Improve Tracking Of Drug Safety Issues
The Food and Drug Administration on Thursday moved to streamline its tracking of potential postmarket drug problems, releasing draft guidelines for a new way to prioritize different problems within the agency's...To view the full article, register now.
Already a subscriber? Click here to view full article